Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
RDY Quote, Financials, Valuation and Earnings
Last price:
$14.70
Seasonality move
:
2.44%
Day range:
$14.54 - $14.73
52-week range:
$12.26 - $16.89
Dividend yield:
0.65%
P/E ratio:
22.36x
P/S ratio:
3.18x
P/B ratio:
3.14x
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
-6.67%
Market cap:
$12.2B
Revenue:
$3.9B
EPS (TTM):
$0.66
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.9B | $3.1B | $3.4B | $3.9B | |
| Revenue Growth (YoY) | 3.75% | 12.82% | 6.56% | 9.96% | 14.19% | |
| Cost of Revenues | $1.2B | $1.3B | $1.3B | $1.4B | $1.6B | |
| Gross Profit | $1.4B | $1.5B | $1.7B | $2B | $2.3B | |
| Gross Profit Margin | 54.33% | 53.1% | 56.67% | 58.61% | 58.5% | |
| R&D Expenses | $222.4M | $234.7M | $241.7M | $276.3M | $323.9M | |
| Selling, General & Admin | $734.8M | $833.4M | $848.5M | $932.6M | $1.1B | |
| Other Inc / (Exp) | -$85.4M | -$48.7M | $19.5M | $72.4M | $58.2M | |
| Operating Expenses | $943.4M | $1B | $1B | $1.2B | $1.4B | |
| Operating Income | $442.5M | $482.2M | $736.6M | $788.9M | $851.8M | |
| Net Interest Expenses | $1.9M | -- | $3.1M | -- | $1.8M | |
| EBT. Incl. Unusual Items | $355.1M | $433.6M | $752.9M | $868.2M | $908.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $123.4M | $117.2M | $190.8M | $195.5M | $231.1M | |
| Net Income to Company | $231.8M | $316.4M | $562.1M | $672.6M | $677.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8.3M | |
| Net Income to Common Excl Extra Items | $231.8M | $316.4M | $562.1M | $672.6M | $668.8M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.38 | $0.68 | $0.81 | $0.80 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.38 | $0.68 | $0.81 | $0.80 | |
| Weighted Average Basic Share | $829.2M | $829.4M | $830.2M | $832M | $833M | |
| Weighted Average Diluted Share | $831.6M | $831.7M | $831.9M | $833.5M | $834.2M | |
| EBITDA | $540.2M | $605.2M | $928.3M | $1.1B | $1.1B | |
| EBIT | $368.2M | $446.4M | $770.7M | $888.8M | $941.7M | |
| Revenue (Reported) | $2.6B | $2.9B | $3.1B | $3.4B | $3.9B | |
| Operating Income (Reported) | $442.5M | $482.2M | $736.6M | $788.9M | $851.8M | |
| Operating Income (Adjusted) | $368.2M | $446.4M | $770.7M | $888.8M | $941.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $648.4M | $722.9M | $766.6M | $852.9M | $982M | |
| Revenue Growth (YoY) | 6.26% | 11.48% | 6.04% | 11.26% | 15.14% | |
| Cost of Revenues | $300.5M | $340.7M | $328.3M | $353.4M | $436.4M | |
| Gross Profit | $348M | $382.2M | $438.2M | $499.5M | $545.6M | |
| Gross Profit Margin | 53.67% | 52.87% | 57.17% | 58.57% | 55.56% | |
| R&D Expenses | $56.1M | $57.5M | $65.3M | $82.8M | $83.8M | |
| Selling, General & Admin | $197.1M | $208.4M | $219M | $246.6M | $277.7M | |
| Other Inc / (Exp) | -$16.6M | -$98.5M | $925.2K | $32.3M | $32.3M | |
| Operating Expenses | $245.1M | $262.1M | $279.2M | $339.6M | $345.4M | |
| Operating Income | $102.9M | $120.1M | $159M | $159.9M | $200.3M | |
| Net Interest Expenses | $1.8M | -- | -- | -- | $1.1M | |
| EBT. Incl. Unusual Items | $84.5M | $33M | $161.4M | $192.9M | $231.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $34.8M | $21.4M | $44.6M | $35.5M | $48.3M | |
| Net Income to Company | $47.7M | $13.6M | $130.1M | $160.9M | $187.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $762K | |
| Net Income to Common Excl Extra Items | $49.7M | $11.6M | $116.8M | $157.4M | $184M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.01 | $0.14 | $0.19 | $0.22 | |
| Diluted EPS (Cont. Ops) | $0.09 | $0.01 | $0.14 | $0.19 | $0.22 | |
| Weighted Average Basic Share | $828.9M | $829.8M | $830.5M | $832.4M | $833M | |
| Weighted Average Diluted Share | $831.4M | $831.7M | $832.3M | $834.3M | $834.3M | |
| EBITDA | $132M | $159.4M | $204.5M | $244.7M | $291.7M | |
| EBIT | $88.6M | $120.1M | $165.7M | $200M | $239.1M | |
| Revenue (Reported) | $648.4M | $722.9M | $766.6M | $852.9M | $982M | |
| Operating Income (Reported) | $102.9M | $120.1M | $159M | $159.9M | $200.3M | |
| Operating Income (Adjusted) | $88.6M | $120.1M | $165.7M | $200M | $239.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.9B | $3.1B | $3.4B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.3B | $1.3B | $1.4B | $1.6B | |
| Gross Profit | $1.4B | $1.5B | $1.7B | $2B | $2.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $222.4M | $234.7M | $241.1M | $276.2M | $323.6M | |
| Selling, General & Admin | $735.3M | $833.3M | $846.4M | $932.3M | $1.1B | |
| Other Inc / (Exp) | -$86.3M | -$62.6M | $21M | $62.2M | $49.4M | |
| Operating Expenses | $943.8M | $1B | $996M | $1.2B | $1.4B | |
| Operating Income | $442.3M | $481.4M | $734.4M | $789.2M | $851.8M | |
| Net Interest Expenses | $2M | -- | $3.2M | -- | -- | |
| EBT. Incl. Unusual Items | $353.9M | $434.4M | $752.3M | $868.3M | $907.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $123.3M | $117.2M | $190.3M | $195.6M | $231.4M | |
| Net Income to Company | $231.8M | $316.4M | $562.1M | $672.6M | $677.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8.4M | |
| Net Income to Common Excl Extra Items | $230.7M | $317.2M | $562.1M | $672.7M | $668M | |
| Basic EPS (Cont. Ops) | $0.31 | $0.38 | $0.68 | $0.64 | $0.66 | |
| Diluted EPS (Cont. Ops) | $0.31 | $0.38 | $0.68 | $0.64 | $0.66 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $539M | $688.8M | $927.5M | $1.1B | $1.1B | |
| EBIT | $367M | $530.1M | $770.1M | $874.5M | $923.2M | |
| Revenue (Reported) | $2.6B | $2.9B | $3.1B | $3.4B | $3.8B | |
| Operating Income (Reported) | $442.3M | $481.4M | $734.4M | $789.2M | $851.8M | |
| Operating Income (Adjusted) | $367M | $530.1M | $770.1M | $874.5M | $923.2M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.1B | $3.4B | $3.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.3B | $1.4B | $1.6B | -- | |
| Gross Profit | $1.5B | $1.7B | $2B | $2.3B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $234.7M | $241.1M | $276.2M | $323.6M | -- | |
| Selling, General & Admin | $833.3M | $846.4M | $932.3M | $1.1B | -- | |
| Other Inc / (Exp) | -$62.6M | $21M | $62.2M | $49.4M | -- | |
| Operating Expenses | $1B | $996M | $1.2B | $1.4B | -- | |
| Operating Income | $481.4M | $734.4M | $789.2M | $851.8M | -- | |
| Net Interest Expenses | -- | $4.6M | -- | $3.5M | -- | |
| EBT. Incl. Unusual Items | $434.4M | $752.3M | $868.3M | $907.8M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $117.2M | $190.3M | $195.6M | $231.4M | -- | |
| Net Income to Company | $316.4M | $562.1M | $672.6M | $677.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -$8.4M | -- | |
| Net Income to Common Excl Extra Items | $317.2M | $562.1M | $672.7M | $668M | -- | |
| Basic EPS (Cont. Ops) | $0.38 | $0.68 | $0.64 | $0.66 | -- | |
| Diluted EPS (Cont. Ops) | $0.38 | $0.68 | $0.64 | $0.66 | -- | |
| Weighted Average Basic Share | $3.3B | $3.3B | $3.3B | $3.3B | -- | |
| Weighted Average Diluted Share | $3.3B | $3.3B | $3.3B | $3.3B | -- | |
| EBITDA | $688.8M | $927.5M | $1.1B | $1.1B | -- | |
| EBIT | $530.1M | $770.1M | $874.5M | $923.2M | -- | |
| Revenue (Reported) | $2.9B | $3.1B | $3.4B | $3.8B | -- | |
| Operating Income (Reported) | $481.4M | $734.4M | $789.2M | $851.8M | -- | |
| Operating Income (Adjusted) | $530.1M | $770.1M | $874.5M | $923.2M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $201.9M | $195.9M | $70.4M | $85.2M | $171.3M | |
| Short Term Investments | $268.8M | $389.2M | $682.3M | $891.7M | $505.7M | |
| Accounts Receivable, Net | $675.9M | $880.5M | $882.9M | $962.9M | $1.1B | |
| Inventory | $618.3M | $671.1M | $592.8M | $762.1M | $831.1M | |
| Prepaid Expenses | $15.5M | $15M | $50.9M | $56.9M | $79.1M | |
| Other Current Assets | $55.4M | $43.4M | $63M | $33.2M | $46.8M | |
| Total Current Assets | $2B | $2.4B | $2.5B | $3B | $2.9B | |
| Property Plant And Equipment | $777.6M | $819.9M | $809.5M | $921.9M | $1.1B | |
| Long-Term Investments | $113.5M | $105.3M | $65.3M | $63M | $177.7M | |
| Goodwill | $62.2M | $58.3M | $51.7M | $51M | $138.1M | |
| Other Intangibles | $485.3M | $359.3M | $375.7M | $443.1M | $1.1B | |
| Other Long-Term Assets | $2.3M | $3M | $1.6M | $10.6M | $2.6M | |
| Total Assets | $3.6B | $3.9B | $3.9B | $4.6B | $5.8B | |
| Accounts Payable | $172.9M | $210.6M | $217.5M | $258.4M | $234.4M | |
| Accrued Expenses | $242.6M | $264.5M | $266.1M | $297.2M | $293.9M | |
| Current Portion Of Long-Term Debt | -- | -- | $46.3M | -- | $444.8M | |
| Current Portion Of Capital Lease Obligations | $11.8M | $13.4M | $12.2M | $15.7M | $10M | |
| Other Current Liabilities | $32.5M | $33M | $45.5M | $72.4M | $86M | |
| Total Current Liabilities | $1.1B | $1.2B | $1B | $1.2B | $1.5B | |
| Long-Term Debt | $51.7M | $50.1M | -- | $45.6M | $44.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.3B | $1.1B | $1.3B | $1.8B | |
| Common Stock | $11.3M | $11M | $10.1M | $10M | $9.8M | |
| Other Common Equity Adj | $18.1M | $10M | $10.8M | $7.8M | $46.5M | |
| Common Equity | $2.4B | $2.5B | $2.8B | $3.4B | $3.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $44.2M | |
| Total Equity | $2.4B | $2.5B | $2.8B | $3.4B | $3.9B | |
| Total Liabilities and Equity | $3.6B | $3.9B | $3.9B | $4.6B | $5.8B | |
| Cash and Short Terms | $470.7M | $585.1M | $752.7M | $976.9M | $677M | |
| Total Debt | $366.9M | $407.3M | $136.3M | $198.1M | $489.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $201.9M | $195.9M | $70.4M | $85.2M | $171.3M | |
| Short Term Investments | $268.8M | $389.2M | $682.3M | $891.7M | $505.7M | |
| Accounts Receivable, Net | $675.9M | $880.5M | $882.9M | $962.9M | $1.1B | |
| Inventory | $618.3M | $671.1M | $592.8M | $762.1M | $831.1M | |
| Prepaid Expenses | $15.5M | $15M | $50.9M | $56.9M | $79.1M | |
| Other Current Assets | $55.4M | $43.4M | $63M | $33.2M | $46.8M | |
| Total Current Assets | $2B | $2.4B | $2.5B | $3B | $2.9B | |
| Property Plant And Equipment | $777.6M | $819.9M | $809.5M | $921.9M | $1.1B | |
| Long-Term Investments | $113.5M | $105.3M | $65.3M | $63M | $177.7M | |
| Goodwill | $62.2M | $58.3M | $51.7M | $51M | $138.1M | |
| Other Intangibles | $485.3M | $359.3M | $375.7M | $443.1M | $1.1B | |
| Other Long-Term Assets | $2.3M | $3M | $1.6M | $10.6M | $2.6M | |
| Total Assets | $3.6B | $3.9B | $3.9B | $4.6B | $5.8B | |
| Accounts Payable | $172.9M | $210.6M | $217.5M | $258.4M | $234.4M | |
| Accrued Expenses | $242.6M | $264.5M | $266.1M | $297.2M | $293.9M | |
| Current Portion Of Long-Term Debt | -- | -- | $46.3M | -- | $444.8M | |
| Current Portion Of Capital Lease Obligations | $11.8M | $13.4M | $12.2M | $15.7M | $10M | |
| Other Current Liabilities | $32.5M | $33M | $45.5M | $72.4M | $86M | |
| Total Current Liabilities | $1.1B | $1.2B | $1B | $1.2B | $1.5B | |
| Long-Term Debt | $51.7M | $50.1M | -- | $45.6M | $44.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.3B | $1.1B | $1.3B | $1.8B | |
| Common Stock | $11.3M | $11M | $10.1M | $10M | $9.8M | |
| Other Common Equity Adj | $18.1M | $10M | $10.8M | $7.8M | $46.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $44.2M | |
| Total Equity | $2.4B | $2.5B | $2.8B | $3.4B | $3.9B | |
| Total Liabilities and Equity | $3.6B | $3.9B | $3.9B | $4.6B | $5.8B | |
| Cash and Short Terms | $470.7M | $585.1M | $752.7M | $976.9M | $677M | |
| Total Debt | $366.9M | $407.3M | $136.3M | $198.1M | $489.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $231.8M | $316.4M | $562.1M | $672.6M | $677.1M | |
| Depreciation & Amoritzation | $172.1M | $158.7M | $157.6M | $179.3M | $201.8M | |
| Stock-Based Compensation | $7.9M | $7.9M | $5M | $4.9M | $5M | |
| Change in Accounts Receivable | $28M | -$228.4M | -$71.7M | -$97.3M | -$121.6M | |
| Change in Inventories | -$166.8M | -$133.1M | -$33.1M | -$222.8M | -$150.9M | |
| Cash From Operations | $480.1M | $377.3M | $734.3M | $548.8M | $549.2M | |
| Capital Expenditures | $168.9M | $255.7M | $235.3M | $331.4M | $406.9M | |
| Cash Acquisitions | -$208.6M | -$4.4M | -- | -$145K | -$631.8M | |
| Cash From Investing | -$304.7M | -$354.2M | -$516M | -$486.6M | -$687M | |
| Dividends Paid (Ex Special Dividend) | -$55.8M | -$55.7M | -$62.1M | -$80.3M | -$78.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $142.4M | -- | -- | $45.9M | -- | |
| Long-Term Debt Repaid | -$60.5M | -$10.5M | -$12.7M | -$59.8M | -$15.3M | |
| Repurchase of Common Stock | -$16M | -- | -- | -- | -$16.4M | |
| Other Financing Activities | -- | -- | -- | -- | $83.5M | |
| Cash From Financing | -$4M | -$32.5M | -$335M | -$45.5M | $223.7M | |
| Beginning Cash (CF) | $26.4M | $198.9M | $185.2M | $69.8M | $84.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $171.4M | -$9.4M | -$116.7M | $16.8M | $85.9M | |
| Ending Cash (CF) | $199.3M | $199.4M | $72.1M | $85.8M | $172.6M | |
| Levered Free Cash Flow | $311.2M | $121.6M | $499M | $217.4M | $142.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $47.7M | $13.6M | $130.1M | $160.9M | $187.4M | |
| Depreciation & Amoritzation | $41.9M | $40.5M | $42.6M | $45.6M | $53.8M | |
| Stock-Based Compensation | $1.7M | $1.9M | $372.8K | $1.2M | $1.3M | |
| Change in Accounts Receivable | $49.2M | -$56.7M | $28.6M | -$23.6M | $20.8M | |
| Change in Inventories | -$48.1M | -$189.9M | -$2.3M | -$48.1M | -$4.2M | |
| Cash From Operations | $149.6M | $124M | $257M | $141.5M | $260M | |
| Capital Expenditures | $42.4M | $55.3M | $51.2M | $77.4M | $132.8M | |
| Cash Acquisitions | $1.2M | -- | -- | -$840 | -$19.1M | |
| Cash From Investing | -$126.1M | -$295.5M | -$204.3M | -$139.1M | -$156.9M | |
| Dividends Paid (Ex Special Dividend) | $311.6K | -$347.1K | -$1.5M | -$463.3K | $55.3K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $91M | -- | -- | $264.8K | -- | |
| Long-Term Debt Repaid | -$2.2M | $25M | -$4.2M | -$3.5M | -$3M | |
| Repurchase of Common Stock | -$13.5M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $116.8M | $67.8M | -$60.3M | -$6.7M | -$87.4M | |
| Beginning Cash (CF) | $58.4M | $293.2M | $76.2M | $90.5M | $154.3M | |
| Foreign Exchange Rate Adjustment | $572.9K | $8.7M | -$987.3K | -$784.8K | $2.8M | |
| Additions / Reductions | $140.4M | -$103.7M | -$7.5M | -$4.3M | $15.6M | |
| Ending Cash (CF) | $199.3M | $199.4M | $72.1M | $85.8M | $172.6M | |
| Levered Free Cash Flow | $107.3M | $68.7M | $205.8M | $64.2M | $127.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $231.8M | $316.4M | $562.1M | $672.6M | $677.1M | |
| Depreciation & Amoritzation | $172.1M | $158.7M | $157.6M | $179.3M | $201.8M | |
| Stock-Based Compensation | $7.9M | $7.9M | $5M | $4.9M | $5M | |
| Change in Accounts Receivable | $28M | -$228.4M | -$71.7M | -$97.3M | -$121.6M | |
| Change in Inventories | -$166.8M | -$133.1M | -$33.1M | -$222.8M | -$150.9M | |
| Cash From Operations | $480.1M | $377.3M | $734.3M | $548.8M | $549.2M | |
| Capital Expenditures | $168.9M | $255.7M | $235.3M | $331.4M | $406.9M | |
| Cash Acquisitions | -$208.6M | -- | -- | -$145K | -$631.8M | |
| Cash From Investing | -$304.7M | -$354.2M | -$516M | -$486.6M | -$687M | |
| Dividends Paid (Ex Special Dividend) | -$55.8M | -$55.7M | -$62.1M | -$80.3M | -$78.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $142.4M | -- | -- | $45.9M | -- | |
| Long-Term Debt Repaid | -$60.5M | -$10.5M | -$12.7M | -$59.8M | -$15.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$4M | -$32.5M | -$335M | -$45.5M | $223.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $171.4M | -$9.4M | -$116.7M | $16.8M | $85.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $311.2M | $121.6M | $499M | $217.4M | $142.3M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $316.4M | $562.1M | $672.6M | $677.1M | -- | |
| Depreciation & Amoritzation | $158.7M | $157.6M | $179.3M | $201.8M | -- | |
| Stock-Based Compensation | $7.9M | $5M | $4.9M | $5M | -- | |
| Change in Accounts Receivable | -$228.4M | -$71.7M | -$97.3M | -$121.6M | -- | |
| Change in Inventories | -$133.1M | -$33.1M | -$222.8M | -$150.9M | -- | |
| Cash From Operations | $377.3M | $734.3M | $548.8M | $549.2M | -- | |
| Capital Expenditures | $255.7M | $235.3M | $331.4M | $406.9M | -- | |
| Cash Acquisitions | -- | -- | -$145K | -$631.8M | -- | |
| Cash From Investing | -$354.2M | -$516M | -$486.6M | -$687M | -- | |
| Dividends Paid (Ex Special Dividend) | -$55.7M | -$62.1M | -$80.3M | -$78.8M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $45.9M | -- | -- | |
| Long-Term Debt Repaid | -$10.5M | -$12.7M | -$59.8M | -$15.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$32.5M | -$335M | -$45.5M | $223.7M | -- | |
| Beginning Cash (CF) | $739.6M | $464.3M | $412.5M | $433M | -- | |
| Foreign Exchange Rate Adjustment | $9.8M | $3.6M | -$712.7K | $2.6M | -- | |
| Additions / Reductions | -$9.4M | -$116.7M | $16.8M | $85.9M | -- | |
| Ending Cash (CF) | $738M | $343.9M | $428M | $520.5M | -- | |
| Levered Free Cash Flow | $121.6M | $499M | $217.4M | $142.3M | -- | |
Get RDY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RDY
Sector
P/E ratio
22.36x
23.88x
PEG ratio
6.68x
0.00x
P/B ratio
3.14x
1.80x
Price / LTM sales
3.18x
1.65x
Growth Metrics
RDY
Sector
Revenue growth
15.14%
4.06%
Earnings growth
16.59%
7.46%
Revenue (5-year growth)
9.39%
8.01%
Earnings forecast
$0.19
-$0.20
Profitability
RDY
Sector
Profitability FY 2024
$2.3B
$47.5M
Return on invested capital
16.41%
-16.26%
Return on assets
12.58%
-13.27%
Return on equity
18.27%
-18.61%
Earnings Date
Last Earnings Date
May
9
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Aug
8
Balance Sheet
RDY
Sector
Total cash
$677M
$35.5M
Short term investments
$505.7M
$29.7M
Total assets
$5.8B
$106.9M
Long term debt
$489.2M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
